Another term for cervical dysplasia is cervical intraepithelial neoplasia, or CIN. The exact cause of cervical dysplasia is not known, however it has been linked to the human papillomavirus (HPV).

In total, 779 women (median age, 39.2 years) underwent LEEP showing CIN2/3; 638 (81.9%) women had CIN3 and 390 (50.1% ... require additional ablative/excisional procedures to reduce the cervical ...

Total Age group-specific Cases of Cervical Dysplasia (CIN 2+, with the impact of HPV vaccination) The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in ...

Background: This study was conducted to determine whether use of hormonal contraceptives is associated with cervical dysplasia and cancer ... and thirty six cases CIN I (72), II (59), III (54 ...

Only 45.5% of patients completed guideline-concordant surveillance within 30 months after treatment for high-grade cervical dysplasia.

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia ... to CIN1 or no dysplasia) was ...

Cervical intraepithelial neoplasia (CIN) is a dysplastic ... Of the 566 women living with HIV, 291 (51.4%) had positive margins (142 [48.8%] ectocervical and 149 [51.2%] endocervical) at the time of ...